Non-Invasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Sponsor
Sequenom, Inc. (Industry)
Overall Status
Completed
CT.gov ID
NCT00770458
Collaborator
(none)
1,000
7
18
142.9
7.9
Study Details
Study Description
Brief Summary
Validate that circulating cell free fetal nucleic acid can be used to identify a direct marker for fetal aneuploidy, particularly fetal Down Syndrome (DS), that is better than surrogate markers.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
1000 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
Non-Invasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Study Start Date
:
Jun 1, 2008
Actual Primary Completion Date
:
Oct 1, 2009
Actual Study Completion Date
:
Dec 1, 2009
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Pregnant women Pregnant women that will undergo standard of care procedures to evaluate fetus for Down Syndrome |
Outcome Measures
Primary Outcome Measures
- Compare investigational assay results for Down Syndrome to standard of care results. [3 months]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
Subject is female
-
Subject is pregnant
-
Subject is high risk aneuploid patient undergoing genetic counseling, unltrasound screening, amniocentesis and/or CVS procedure
-
Subject is willing to provide blood specimen
Exclusion Criteria:
-
Subject is not pregnant
-
Subject is not willing to provide blood specimen
-
Subject is not haveing aneuploid screening
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | UCSD Fetal Care & Genetics Center | La Jolla | California | United States | 92037 |
2 | San Diego Perinatal Center | San Diego | California | United States | 92123 |
3 | Obstetrix Medical Group of San Jose | San Jose | California | United States | 95008 |
4 | Obstetrix Medical Group of Colorado | Denver | Colorado | United States | 80218 |
5 | Women & Infants | Providence | Rhode Island | United States | 02903 |
6 | A.R.U.P. | Salt Lake City | Utah | United States | 84108 |
7 | Obstetrix Medical Group of Washington | Seattle | Washington | United States | 98104 |
Sponsors and Collaborators
- Sequenom, Inc.
Investigators
- Study Director: Allan Bombard, MD, Sequenom, Inc.
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00770458
Other Study ID Numbers:
- SQNM-Trisomy21-0100
First Posted:
Oct 10, 2008
Last Update Posted:
Jan 6, 2010
Last Verified:
Jan 1, 2010
Keywords provided by ,
,
Additional relevant MeSH terms: